ECOSLOPS (ALESA.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALESA • FR0011490648

0.82 EUR
0 (0%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Overall ALESA gets a fundamental rating of 2 out of 10. We evaluated ALESA against 43 industry peers in the Commercial Services & Supplies industry. ALESA may be in some trouble as it scores bad on both profitability and health. ALESA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ALESA has reported negative net income.
  • In the past year ALESA had a positive cash flow from operations.
  • ALESA had negative earnings in each of the past 5 years.
  • In the past 5 years ALESA reported 4 times negative operating cash flow.
ALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M -10M

1.2 Ratios

  • The Return On Assets of ALESA (-12.91%) is worse than 76.74% of its industry peers.
  • With a Return On Equity value of -76.91%, ALESA is not doing good in the industry: 81.40% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -12.91%
ROE -76.91%
ROIC N/A
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ALESA.PA Yearly ROA, ROE, ROICALESA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 64.42%, ALESA is in the better half of the industry, outperforming 72.09% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALESA has grown nicely.
  • ALESA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
ALESA.PA Yearly Profit, Operating, Gross MarginsALESA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • ALESA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALESA has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALESA has more shares outstanding
  • Compared to 1 year ago, ALESA has a worse debt to assets ratio.
ALESA.PA Yearly Shares OutstandingALESA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALESA.PA Yearly Total Debt VS Total AssetsALESA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • ALESA has an Altman-Z score of -1.64. This is a bad value and indicates that ALESA is not financially healthy and even has some risk of bankruptcy.
  • ALESA has a worse Altman-Z score (-1.64) than 81.40% of its industry peers.
  • ALESA has a debt to FCF ratio of 48.08. This is a negative value and a sign of low solvency as ALESA would need 48.08 years to pay back of all of its debts.
  • ALESA's Debt to FCF ratio of 48.08 is on the low side compared to the rest of the industry. ALESA is outperformed by 62.79% of its industry peers.
  • ALESA has a Debt/Equity ratio of 3.78. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ALESA (3.78) is worse than 83.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF 48.08
Altman-Z -1.64
ROIC/WACCN/A
WACC10.48%
ALESA.PA Yearly LT Debt VS Equity VS FCFALESA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • ALESA has a Current Ratio of 2.76. This indicates that ALESA is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ALESA (2.76) is better than 90.70% of its industry peers.
  • A Quick Ratio of 2.48 indicates that ALESA has no problem at all paying its short term obligations.
  • ALESA has a better Quick ratio (2.48) than 90.70% of its industry peers.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.48
ALESA.PA Yearly Current Assets VS Current LiabilitesALESA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • ALESA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.51%.
  • The Revenue has been growing slightly by 4.19% in the past year.
  • ALESA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.43% yearly.
EPS 1Y (TTM)5.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.8%
Revenue 1Y (TTM)4.19%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%-2.41%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALESA.PA Yearly Revenue VS EstimatesALESA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALESA.PA Yearly EPS VS EstimatesALESA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • ALESA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • ALESA is valuated cheaply with a Price/Forward Earnings ratio of 1.61.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALESA indicates a rather cheap valuation: ALESA is cheaper than 100.00% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.97. ALESA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 1.61
ALESA.PA Price Earnings VS Forward Price EarningsALESA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, ALESA is valued a bit cheaper than 62.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.44
EV/EBITDA N/A
ALESA.PA Per share dataALESA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

  • ALESA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALESA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ECOSLOPS

EPA:ALESA (2/10/2026, 7:00:00 PM)

0.82

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)01-22
Earnings (Next)N/A
Inst Owners12.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.26M
Revenue(TTM)11.36M
Net Income(TTM)-3.07M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.61
P/S 0.37
P/FCF 12.44
P/OCF 3.54
P/B 1.06
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)0.51
Fwd EY62.18%
FCF(TTM)0.07
FCFY8.04%
OCF(TTM)0.23
OCFY28.27%
SpS2.19
BVpS0.77
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.91%
ROE -76.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.42%
FCFM 3.01%
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF 48.08
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 7.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.76
Quick Ratio 2.48
Altman-Z -1.64
F-Score4
WACC10.48%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.97%
Cap/Sales(5y)39.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.8%
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.19%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%-2.41%
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-198.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1271.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y197.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y155.96%
OCF growth 3YN/A
OCF growth 5YN/A

ECOSLOPS / ALESA.PA FAQ

What is the fundamental rating for ALESA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALESA.PA.


What is the valuation status of ECOSLOPS (ALESA.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to ECOSLOPS (ALESA.PA). This can be considered as Fairly Valued.


How profitable is ECOSLOPS (ALESA.PA) stock?

ECOSLOPS (ALESA.PA) has a profitability rating of 1 / 10.


How financially healthy is ECOSLOPS?

The financial health rating of ECOSLOPS (ALESA.PA) is 3 / 10.


What is the expected EPS growth for ECOSLOPS (ALESA.PA) stock?

The Earnings per Share (EPS) of ECOSLOPS (ALESA.PA) is expected to grow by 211.24% in the next year.